Programmed death 1 (PD-1) is a cell surface co-receptor in the CD28/CTLA-4 T-cell family and functions as a down regulator of the immune system through a dual mechanism of inhibition.
PD-1 is expressed on activated T-cells, B-cells, and myeloid cells, and is a marker ofangioimmunoblastic lymphoma and suggests a unique cell of origin for this neoplasm.
The presence of PD-1 positive tumor-infiltrating lymphocytes (TIL) has been associated with poor prognosis in human breast cancers and may be useful in antibody therapy targeting the PD-1/PD-L1 signaling pathway. Treatments targeting PD-1 and its ligand, PD-L1, have also shown encouraging results in non-small-cell lung cancer, renal cell carcinoma and melanoma.
Subcellularlocation:
Membrane
Recommendedmethod:
Heat induced epitope retrieval with Tris-EDTA buffer (pH 9.0), primary antibody incubate at RT (18°C-25°C) for 30 minutes.
Immunogen:
Recombinant full length protein corresponding to Human PD-1. The immunogen contains
the specific extracellular domain of huPD1 (L25-Q167).
您好!请登录